Scientech Research »

Plus Therapeutics shares owned by Scientech Research

Quarter-by-quarter ownership of Plus Therapeutics (PSTV) shares owned by Scientech Research from 13F filings

Historical chart of Scientech Research investment in Plus Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Plus Therapeutics held by Scientech Research consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Plus Therapeutics by Scientech Research

Quarter filed Position value Share count Share price at filing
2025-09-30 $100k 147k 0.68

More positions owned by Scientech Research

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Applovin Corp Com Cl A (APP)
Eli Lilly & Co. (LLY)
Regeneron Pharmaceuticals (REGN)
Alnylam Pharmaceuticals (ALNY)
Tilray (TLRY)
Uniqure Nv SHS (QURE)
Mongodb Cl A (MDB)
Insulet Corporation (PODD)
Transocean Registered Shs (RIG)
Zebra Technologies Corporati Cl A (ZBRA)
Robinhood Mkts Com Cl A (HOOD)
Graniteshares Etf Tr 2x Long Nvda Dai (NVDL)
Adobe Systems Incorporated (ADBE)

View all positions for Scientech Research

Top funds holding Plus Therapeutics

Vanguard Group
Altium Capital Management
Geode Capital Management
UBS Group
BlackRock
State Street Corporation
Northern Trust
Scientech Research
Susquehanna International
Mercer Global Advisors
Dagco
Kestra Advisory Services
Cubist Systematic Strategies
Two Sigma Securities
Cambridge Investment Research Advisors

View all funds holding Plus Therapeutics